Alafair Biosciences Announces VersaWrap-® Tendon Protector Sales Milestone
AUSTIN, Texas, May 23, 2019 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that sales of its initial product, VersaWrap® Tendon Protector (VersaWrap), have now exceeded 500 units since commercial launch. The rapid sales growth reflects expanding surgeon adoption and the significant clinical need for VersaWrap. VersaWrap is an ultrathin,...
Read More »Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
PALO ALTO, California and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact single-room proton therapy system at Biopolis, an international biomedical research hub. The cyclotron is a core piece of equipment in the...
Read More »Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
PALO ALTO, California and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact single-room proton therapy system at Biopolis, an international biomedical research hub. The cyclotron is a core piece of equipment in the...
Read More »US Physicians Now Treating Patients with BIOTRONIK's Ultraslim Acticor DX Devices
Lake Oswego, Ore., April 29, 2019 /PRNewswire/ -- BIOTRONIK today announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading electrophysiologists throughout the United States are now treating patients with the new implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). When implanted...
Read More »The Ultimate Guide to Enclosed Tubular Drag Cable and Disc Conveyors
This whitepaper provides a comprehensive overview of enclosed tubular drag cable and disc conveyors.
Read More »US Physicians Now Treating Patients with BIOTRONIK's Ultraslim Acticor DX Devices
Lake Oswego, Ore., April 29, 2019 /PRNewswire/ -- BIOTRONIK today announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading electrophysiologists throughout the United States are now treating patients with the new implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). When implanted...
Read More »Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.5 and Total Daily Insulin Dosage by 14%
BRIDGEWATER, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced results from the VERDICT study at the American Association of Clinical Endocrinologists (AACE) Annual Meeting. The VERDICT study demonstrated that patients with type 2 diabetes who switched to V-Go can...
Read More »Valeritasâ™ V-Go-® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.5 and Total Daily Insulin Dosage by 14%
BRIDGEWATER, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced results from the VERDICT study at the American Association of Clinical Endocrinologists (AACE) Annual Meeting. The VERDICT study demonstrated that patients with type 2 diabetes who switched to V-Go can...
Read More »Raytheon Developing Portable Friend or Foe System to Identify Harmful Bacteria Before they Cause Harm
CAMBRIDGE, Mass., April 23, 2019 /PRNewswire/ -- Raytheon (NYSE: RTN) is developing a portable device to evaluate bacteria and their potential to cause harm—information that could support the future development of medical countermeasures and improved screening tools. Under the DARPA Friend or Foe program, Raytheon is developing biosurveillance technology that detects bacterial pathogens as soon...
Read More »Raytheon Developing Portable Friend or Foe System to Identify Harmful Bacteria Before they Cause Harm
CAMBRIDGE, Mass., April 23, 2019 /PRNewswire/ -- Raytheon (NYSE: RTN) is developing a portable device to evaluate bacteria and their potential to cause harm—information that could support the future development of medical countermeasures and improved screening tools. Under the DARPA Friend or Foe program, Raytheon is developing biosurveillance technology that detects bacterial pathogens as soon...
Read More »New IdentiTi Porous Titanium Interbody System Features Reduced Density (60% porous), Allowing Improved Intraoperative and Postoperative Imaging
Designed to provide the biological, biomechanical and imaging features that surgeons seek in a fusion construct. Includes predictable performance associated with the subtractive manufacturing process, creating a porous titanium material with consistent and reproducible interconnected pore sizes. Features pore structure and an architecture that enables both immediate and long-term stability.
Read More »DoorKing's 1601 Lane Barrier Provides a Higher Level of Traffic Control for Less
DoorKing is proud to introduce an easy add-on to its 1601 Barrier Gate Operator: The 1601 Traffic Lane Barrier. The barrier gate provides greater traffic control while eliminating the need for bollards or crash beams. Check out this video to learn more.
Read More »